GlassScriptPhysician profile
Alexandra Otto
NPI 1770015364
$6,398.16
in general payments reported to CMS, 2019-2025
11 companies · $6,155 in 2025
The $6,155 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.34 · 2022: $46.57 · 2023: $34.48 · 2024: $95.13 · 2025: $6,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,533 · Travel and Lodging: $1,301 · Food and Beverage: $412 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,533.40 |
| Travel and Lodging | $1,300.68 |
| Food and Beverage | $412.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,999.67 | 2025 | |
| Mdd US Operations, LLC | $73.55 | 2024-2025 | Apokyn |
| Exeltis, USA INC. | $71.91 | 2022-2025 | Slynd |
| Abbvie INC. | $53.97 | 2021-2022 | |
| Astellas Pharma US INC | $40.13 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $34.23 | 2021-2023 | |
| Organon LLC | $33.44 | 2022-2024 | |
| Sage Therapeutics, LLC | $33.32 | 2021-2024 | |
| Biogen, INC. | $27.10 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $16.10 | 2025 | |
| Coopersurgical, INC. | $14.74 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Otto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.